Inhibikase Therapeutics Inc (IKT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -35,525 | -23,594 | -13,679 | -27,520 | -15,387 |
| Depreciation Amortization | 61 | 37 | 13 | 26 | 20 |
| Accounts payable and accrued liabilities | -391 | 1,593 | 681 | 272 | 1,329 |
| Other Working Capital | -353 | 1,795 | 1,328 | 205 | 1,333 |
| Other Operating Activity | 15,938 | 10,492 | 7,554 | 7,869 | -1,097 |
| Operating Cash Flow | $-20,271 | $-9,678 | $-4,104 | $-19,148 | $-13,803 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,604 | 31,350 | 21,506 | -37,004 | 1,758 |
| PPE Investments | -13 | -13 | -13 | N/A | N/A |
| Other Investing Activity | -439 | -439 | -439 | 0 | 0 |
| Investing Cash Flow | $2,152 | $30,898 | $21,054 | $-37,004 | $1,758 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 283 | 32 | N/A | 103,478 | 3,793 |
| Other Financing Activity | -385 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $-102 | $32 | $N/A | $103,478 | $3,793 |
| Beginning Cash Position | 56,491 | 56,491 | 56,491 | 9,165 | 9,165 |
| End Cash Position | 38,270 | 77,743 | 73,441 | 56,491 | 913 |
| Net Cash Flow | $-18,221 | $21,252 | $16,951 | $47,325 | $-8,252 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,271 | -9,678 | -4,104 | -19,148 | -13,803 |
| Capital Expenditure | -13 | -13 | -13 | N/A | N/A |
| Free Cash Flow | -20,284 | -9,691 | -4,117 | -19,148 | -13,803 |